Rigel files $125 million shelf covering stock, preferreds and debt

By Devika Patel

Knoxville, Tenn., Dec. 14 - Rigel Pharmaceuticals, Inc. filed a $125 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities, warrants and units.

The securities may be structured as convertibles.

The South San Francisco, Calif., drug development company will use proceeds for research and development and for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.